Cardio Diagnostics (CDIOW) to Release Quarterly Earnings on Wednesday

Cardio Diagnostics (NASDAQ:CDIOW) is expected to announce its results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of ($1.80) per share and revenue of $0.25 million for the quarter.

Cardio Diagnostics Stock Up 11.6%

NASDAQ:CDIOW opened at $0.02 on Friday. The company has a 50 day simple moving average of $0.02 and a two-hundred day simple moving average of $0.02. Cardio Diagnostics has a 12 month low of $0.01 and a 12 month high of $0.09.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.